Claims
- 1. A compound of the formula: ##STR6## in which X, Y and Z are, independently, hydrogen, halogen, hydroxy, nitro, cyano, carboxyl, trifluoromethyl, phenyl, amino, alkylamino of 1 to 6 carbon atoms, dialkylamino in which each alkyl group has 1 to 6 carbon atoms, alkyl of 1 to 6 carbon atoms, alkoxy of 1 to 6 carbon atoms or aralkoxy of 7 to 10 carbon atoms;
- R.sub.1 is quinolinyl optionally substituted by from one to three substituents selected from halogen, hydroxy, nitro, cyano, carboxyl, trifluoromethyl, phenyl, amino, alkylamino of 1 to 6 carbon atoms, dialkylamino in which each alkyl group has 1 to 6 carbon atoms, alkyl of 1 to 6 carbon atoms, or alkoxy of 1 to 6 carbon atoms;
- R.sub.2 is hydrogen, alkyl of 1 to 18 carbon atoms, cycloalkyl of 5 to 8 carbon atoms, phenyl, benzyl or substituted phenyl or benzyl in which said substituent is alkyl of 1 to 6 carbon atoms, alkoxy of 1 to 6 carbon atoms, halogen, cyano, trifluoromethyl, amino, nitro, alkylamino of 1 to 6 carbon atoms or dialkylamino of 1 to 6 carbon atoms;
- or a pharmaceutically acceptable salt thereof.
- 2. A compound of claim 1 of the formula: ##STR7## in which X, Y and Z are, independently, alkyl of 1 to 6 carbon atoms, alkoxy of 1 to 6 carbon atoms, hydroxy, dialkylamino in which each alkyl group has from 1 to 6 carbon atoms or phenylalkyloxy of 7 to 9 carbon atoms;
- R.sub.1 is quinolinyl; and
- R.sub.2 is hydrogen, alkyl of 1 to 18 carbon atoms, cycloalkyl of 5 to 8 carbon atoms, phenyl, benzyl or substituted phenyl or benzyl in which said substituent is alkyl of 1 to 6 carbon atoms, alkoxy of 1 to 6 carbon atoms, halogen, cyano, trifluoromethyl, amino, nitro, alkylamino of 1 to 6 carbon atoms or dialkylamino of 1 to 6 carbon atoms;
- or a pharmaceutically acceptable salt thereof.
- 3. A compound of claim 1 which is 5-[(3,5-di-tert-butyl-4-hydroxy-phenylamino)-(quinolin-3-ylamino)-methylene]-2,2-dimethyl-[1,3]dioxane-4,6-dione or a pharmaceutically acceptable salt thereof.
- 4. A compound of claim 1 which is 5-[(3,5-di-tert-butyl-4-hydroxy-phenylamino)-(quinolin-2-ylamino)-methylene]-2,2-dimethyl-[1,3]dioxane-4,6-dione or a pharmaceutically acceptable salt thereof.
- 5. A compound of claim 1 which is 5-[(3,5-di-tert-butyl-4-hydroxy-phenylamino)-(quinolin-4-ylamino)-methylene]-2,2-dimethyl-[1,3]dioxane-4,6-dione or a pharmaceutically acceptable salt thereof.
- 6. A compound of claim 1 which is 5-[(3,5-di-tert-butyl-4-hydroxy-phenylamino)-(quinolin-5-ylamino)-methylene]-2,2-dimethyl-[1,3]dioxane-4,6-dione or a pharmaceutically acceptable salt thereof.
- 7. A compound of claim 1 which is 5-[(3,5-di-tert-butyl-4-hydroxy-phenylamino)-(quinolin-6-ylamino)-methylene]-2,2-dimethyl-[1,3]dioxane-4,6-dione or a pharmaceutically acceptable salt thereof.
- 8. A compound of claim 1 which is 5-[(3,5-di-tert-butyl-4-hydroxy-phenylamino)-(quinolin-8-ylamino)-methylene]-2,2-dimethyl-[1,3]dioxane-4,6-dione or a pharmaceutically acceptable salt thereof.
RELATED APPLICATION
This is a division of application Ser. No. 07/998,213, filed Dec. 30, 1992, now U.S. Pat. No. 5,281,714, which application is a continuation-in-part of U.S. patent application Ser. No. 07/964,232, filed Oct. 21, 1992, now abandoned, which is a continuation-in-part of Ser. No. 07/719,873, filed Jun. 24, 1991, now U.S. Pat. No. 5,179,216, which in turn is a continuation-in-part of U.S. patent application Ser. No. 07/568,384, filed Aug. 16, 1990, now abandoned.
US Referenced Citations (2)
Number |
Name |
Date |
Kind |
4387105 |
De Vries et al. |
Jun 1983 |
|
4387106 |
De Vries et al. |
Jun 1983 |
|
Non-Patent Literature Citations (4)
Entry |
J. Med. Chem. 29, 1131 (1986), De Vries et al. |
Stephen, Monat. Fur Chemie, 97, 45 (1966). |
Augustin et al., Z. Chem. 30, 169 (1990), same as CA 113:231288t, 1990. |
Augustin et al., CA 113:231288t, 1990. |
Divisions (1)
|
Number |
Date |
Country |
Parent |
998213 |
Dec 1992 |
|
Continuation in Parts (3)
|
Number |
Date |
Country |
Parent |
964232 |
Oct 1992 |
|
Parent |
719873 |
Jun 1991 |
|
Parent |
568384 |
Aug 1990 |
|